x

CanSino recombinant COVID-19 vaccine approved as special military drug

Chinese bio pharmaceutical firm CanSino Biologics Inc announced on Monday that a recombinant
novel coronavirus vaccine (Ad5-nCoV) the company developed with a military research team has
received special one-year military drug approval.
The approval for the military use of Ad5-nCoV was granted by the Health Bureau of the Logistics
Support Department of the Central Military Commission on June 25, for one year, the company
said in a statement sent to the Global Times on Monday. Ad5-nCoV is currently limited to military
use and cannot be expanded to a broader vaccination range without the approval of the Logistics
Support Department, the statement said.  
Ad5-nCoV is being jointly developed by CanSino and a team led by military infectious disease
expert Chen Wei from the Institute of Biotechnology under the Academy of Military Medical
Sciences. 
The vaccine was approved for clinical trials in March. Phase one and two clinical trials for Ad5-
nCoV have been conducted in China, with phase two trials were unveiled on June 11, 2020,
according to CanSino. Data from the clinical trials showed a good safety profile and high levels of
humoral and cellular immune responses. The overall clinical results indicate Ad5-nCoV has the
potential to prevent diseases caused by SARS-CoV-2. According to regulations of the Chinese
People's Liberation Army (PLA) covering drugs, special military drugs are those that the military
uses to prevent and treat war injuries and diseases in special military environments.
Such drugs are limited to military use. Local medical institutes have to obtain the approval of local
provincial-level governments and the military logistics support department to use such drugs,
according to the regulations.
Li Daguang, a professor at the National Defense University of the PLA, told the Global Times on
Monday that the approval process for Ad5-nCoV to become a special military drug followed the
normal procedures. 
The move is mainly intended to encourage and promote COVID-19 vaccine research and
development (R&D) amid the current tough pandemic situation, according to Li.
Global infections reached 10,180,816 as of press time after the number topped 10 million on
Sunday, according to Johns Hopkins University's tracking of the data. 
Li noted that the status of "special military drug" would not affect the normal R&D procedure and
marketing process of the vaccine. 
Special military drugs have to obtain the approval of the military logistics support department and
China's national drug supervision department before being used for civilians, according to the
regulations. 
CanSino announced in May that it had obtained approval from the Canadian National Research
Council to conduct clinical trials for Ad5-nCoV, though it didn't disclose further details.
Source: Global Times

Hot this week

Editors Urge Government To Create Safe, Enabling Environment For Journalists

· Ask security agents to find missing Vanguard journalist As...

EXCLUSIVE: Buhari orders probe of Isa Funtua, AMCON over keystone and Etisalat

Following the controversy generated by the leading opposition party,...

6 Signs your boyfriend thinks you are ugly -Take note of No. 2

They say there are three kinds of people; the...

2023: South-East, Middle Belt Forum Endorses Peter Obi

The South-East and Middle Belt Forum has endorsed the...

Retired Police Officers Set for Nationwide Protest Over Pension Scheme

By Idibia Gabriel, Kaduna The Kaduna State chapter of the...

NUJ Info Chapel Hosts Workshop, Hails Commissioner, Council Leadership

By Amgbare Ekaunkumo, Yenagoa The Bayelsa State Commissioner for Information,...

Tinubu Appoints Ismael Ahmed as Executive Chairman of Presidential CNG Initiative

President Bola Ahmed Tinubu has appointed Barrister Ismael Ahmed...

Alleged ₦80.2bn Fraud: EFCC Kicks as Yahaya Bello Seeks Medical Travel Abroad

By Gabriel Udeh The Economic and Financial Crimes Commission, EFCC,...

Why we’re raising concerns over alleged contract scam at NNPCL – Coalition

President Bola Tinubu has been asked to terminate the...

Tinubu Assures Abuja Residents, No More ” One Chance” Attacks

By Joyce Remi-Babayeju President Bola Tinubu has assured Abuja residents...

INEC Sets August 16 for Bye-Elections in 12 States, Resumes Voter Registration

The Independent National Electoral Commission (INEC) has announced August...

Tinubu Hosts Fubara, Wike, Rivers Lawmakers in Fresh Push for Peace

President Bola Tinubu on Thursday convened a closed-door meeting...
spot_img

Related Articles

Popular Categories

spot_imgspot_img